GE To Enter China’s Medical Home Care Market
This article was originally published in PharmAsia News
Executive Summary
GE Healthcare has announced it will introduce home respiratory and sleep care solutions into China's homes. The Vivo series of electronic ventilators and non-invasive iSleep devices used for home respiratory support and sleep apnea come from Vital Signs and its subsidiary Breas Medical, which were acquired by GE a few years ago. The move represents the firm's first foray into the country's medical home care market, giving it direct access to patients. GE Healthcare sees home health care as an emerging sector with rapid growth and China offers huge market potential. (Click here for more - Chinese Language)
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.